Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Walsh

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Journal of Crohn'S & Colitis|July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current CareDarren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Gut|September 28, 2022
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid responseAlex Adams, Vipin Gupta, Waled Mohsen, et al.
Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.
Journal of Crohn'S & Colitis|September 16, 2022
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative ColitisSally Mortlock, Anton Lord, Grant Montgomery, et al.
Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.
BMC Medical Genetics|August 31, 2017
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score methodGuo-Bo Chen, Sang Hong Lee, Grant W Montgomery, et al.
Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Journal of Crohn'S & Colitis|October 21, 2023
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBDSophie Vieujean, James O Lindsay, Ferdinando D'Amico, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Journal of Crohn'S & Colitis|July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current CareDarren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Gut|September 28, 2022
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid responseAlex Adams, Vipin Gupta, Waled Mohsen, et al.
Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.
Journal of Crohn'S & Colitis|September 16, 2022
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative ColitisSally Mortlock, Anton Lord, Grant Montgomery, et al.
Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.
BMC Medical Genetics|August 31, 2017
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score methodGuo-Bo Chen, Sang Hong Lee, Grant W Montgomery, et al.
Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Journal of Crohn'S & Colitis|October 21, 2023
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBDSophie Vieujean, James O Lindsay, Ferdinando D'Amico, et al.
Pageof 4